You have 9 free searches left this month | for more free features.

Donor stem cell transplant

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Haematological Malignancies Trial in London, Manchester (CD25/71 allodepleted donor T-cells)

Completed
  • Haematological Malignancies
  • CD25/71 allodepleted donor T-cells
  • London, United Kingdom
  • +1 more
Jul 18, 2022

GVHD, Hematopoietic/Lymphoid Cancer Trial in Winston-Salem (fludarabine phosphate, busulfan, cyclophosphamide)

Active, not recruiting
  • Graft Versus Host Disease
  • Hematopoietic/Lymphoid Cancer
  • fludarabine phosphate
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Aug 5, 2022

Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)

Withdrawn
  • Multiple Myeloma
  • Refractory Multiple Myeloma
  • nonmyeloablative allogeneic hematopoietic stem cell transplantation
  • +7 more
  • (no location specified)
Jan 4, 2023

Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Tumor Trial in Houston (Recombinant

Active, not recruiting
  • Allogeneic Hematopoietic Stem Cell Transplant Recipient
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Recombinant Human Papillomavirus Nonavalent Vaccine
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Recurrent Acute Myeloid Leukemia Trial in Nashville (Venetoclax, Decitabine, Cedazuridine)

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Mar 22, 2023

Leukemia Trial (Donor Enriched Activated Natural Killer Cell Infusion)

Withdrawn
  • Leukemia
  • Donor Enriched Activated Natural Killer Cell Infusion
  • (no location specified)
Dec 20, 2022

Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Duarte (Cholestyramine, Leflunomide, Steroid Therapy)

Recruiting
  • Acute Graft Versus Host Disease
  • Hematopoietic and Lymphoid System Neoplasm
  • Duarte, California
    City of Hope Medical Center
Jan 5, 2023

Cytomegaloviral Infection, Hematopoietic Cell Transplant Recipient Trial in Duarte (Laboratory Biomarker Analysis, Multi-peptide

Recruiting
  • Cytomegaloviral Infection
  • Hematopoietic Cell Transplant Recipient
  • Laboratory Biomarker Analysis
  • Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
  • Duarte, California
    City of Hope Medical Center
Jun 14, 2022

Leukemia, MDS Trial in Duarte (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • fludarabine phosphate
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

DOCK8 Deficiency Trial run by the National Cancer Institute (NCI) (Reduced-intensity hematopoietic stem cell,

Recruiting
  • DOCK8 Deficiency
  • Reduced-intensity hematopoietic stem cell
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Scottsdale, Cleveland,

Completed
  • Chronic Myelomonocytic Leukemia
  • +3 more
  • Scottsdale, Arizona
  • +3 more
Jan 12, 2023

Fanconi Anemia Trial in Stanford (drug, device, biological)

Recruiting
  • Fanconi Anemia
  • Stanford, California
    Stanford University
Feb 2, 2022

Allogeneic Stem Cell Transplant, Viral Infection, Viral Reactivation Trial in Cincinnati (Viral specific VST Infusion)

Recruiting
  • Allogeneic Stem Cell Transplant
  • +2 more
  • Viral specific VST Infusion
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Aug 15, 2022

Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,

Recruiting
  • Stem Cell Transplant Complications
  • +4 more
  • Radiation
  • +7 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +13 more
  • CMVpp65-A*0201 peptide vaccine
  • +2 more
  • Duarte, California
  • +4 more
Jan 4, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +14 more
  • Aldesleukin
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

Active, not recruiting
  • Acute Leukemia
  • +14 more
  • Duarte, California
    City of Hope Medical Center
Nov 18, 2022

Acute Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial (Siremadlin)

Recruiting
  • Acute Myeloid Leukemia
  • Allogeneic Stem Cell Transplantation
  • Tel Aviv, Israel
  • +2 more
Jan 23, 2023

Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

Active, not recruiting
  • Multiple Myeloma
  • +4 more
  • Total Body Irradiation
  • +5 more
  • Los Angeles, California
    Cedars Sinai Medical Center
Dec 21, 2022

Respiratory Virus Testing and Home Spirometry for Screening of

Recruiting
  • Bronchiolitis Obliterans Syndrome
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Biospecimen Collection
  • +2 more
  • Palo Alto, California
  • +3 more
Aug 1, 2022

Blastoid Variant Mantle Cell Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Follicular Lymphoma Trial in United

Active, not recruiting
  • Blastoid Variant Mantle Cell Lymphoma
  • +8 more
  • Birmingham, Alabama
  • +4 more
May 10, 2022

Allogeneic Hematopoietic Stem Cell Transplantation Recipient Trial in Columbus (Vitamin A Compound)

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation Recipient
  • Vitamin A Compound
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 24, 2022

Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • +3 more
  • Allogeneic Bone Marrow Transplantation
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Multiple Myeloma Trial in New York (drug, biological, procedure)

Active, not recruiting
  • Multiple Myeloma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2023